Loading...
Budesonide–formoterol (inhalation powder) in the treatment of COPD
The budesonide–formoterol dry powder inhaler (Symbicort(®) Turbuhaler(®) 160/4.5–640/18 μg/day) contains the long-acting β(2)-adrenoreceptor agonist formoterol and the inhaled corticosteroid budesonide. Two large, 12-month trials examined the effect of budesonide–formoterol 160/4.5 μg twice daily in...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2706613/ https://ncbi.nlm.nih.gov/pubmed/18046888 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|